Recently the magazine’s elite panel of judges declared CleanseSMART™ and Ultimate Flora Critical Care 50 Billion™ winners based upon reader feedback and surveys from experts in the medical and nutritional supplements industries. CleanseSMART shined in the Cleansing & Detox category, while Ultimate Flora won for Probiotics supplements. Votes were tallied based on a series of surveys that focused on 31 categories in all—everything from fish oils and antioxidants to multivitamins and herbs—and included questions about quality, ingredients, formulation, cost, customer satisfaction, popularity, and availability. 

CleanseSMART remains one of ReNew Life’s most popular total-body cleanses, with a combination of 23 natural ingredients to promote detoxification, better digestion and overall health. Like all ReNew Life products, it’s free of added ingredients, fillers or binders, because our motto has always been, “Why put more toxins in your body when you’re trying to get them out?”

Ultimate Flora Critical Care 50 Billion is also a favorite among our customers. The high-potency, high-Bifido formula contains 10 powerful strains of beneficial bacteria and provides powerful digestive and immune support by helping to reestablish a healthy balance of good bacteria in the digestive tract. Ideal for those with troublesome digestion or who are taking antibiotics, Ultimate Flora Critical Care 50 Billion uses our unique Enteric-GUARD™ targeted delivery technology and features our exclusive Potent-GUARD™ guarantee.

So thanks to all of you who chose CleanseSMART and Ultimate Flora Critical Care 50 Billion on your journey toward superior health—we couldn’t have done it without your support!

Banned already in more than 60 countries worldwide, endosulfan is used widely on vegetable crops and cotton and has been linked to birth defects and delayed sexual development in children, as well as an increased risk of developing autism. Although not considered a carcinogen, research shows that endosulfan may also contribute to certain types of cancer, in particular breast cancer.

Even though it was re-registered for use in the U.S. under the Bush administration in 2002, PANNA and others have been pushing to remove endosulfan from the market because of documented evidence of health damage to farm workers as well as people and wildlife living near exposed soil and water. The EPA is now working with the sole manufacturer of endosulfan in the U.S. to establish a timeframe that would allow farmers to come up with effective alternatives to endosulfan use.